[Federal Register Volume 77, Number 226 (Friday, November 23, 2012)]
[Notices]
[Page 70189]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-28500]



[[Page 70189]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Cayman Chemical Company

    By Notice dated July 30, 2012, and published in the Federal 
Register on August 7, 2012, 77 FR 47115, Cayman Chemical Company, 1180 
East Ellsworth Road, Ann Arbor, Michigan 48108, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the following basic classes of controlled 
substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)...........................  I
Methcathinone (1237).......................  I
4-Methyl-N-methylcathinone (1248)..........  I
N-Ethylamphetamine (1475)..................  I
N,N-Dimethylamphetamine (1480).............  I
Aminorex (1585)............................  I
4-Methylaminorex (cis isomer) (1590).......  I
Gamma Hydroxybutyric Acid (2010)...........  I
1-Pentyl-3-(1-naphthoyl) indole (7118).....  I
1-Butyl-3-(1-naphthoyl) indole (7173)......  I
1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)   I
 indole (7200).
Alpha-ethyltryptamine (7249)...............  I
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-         I
 hydroxycyclohexyl]-phenol (7297).
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-          I
 hydroxycyclohexyl]-phenol (7298).
Lysergic acid diethylamide (7315)..........  I
2,5-Dimethoxy-4-(n)-                         I
 propylthiophenethylamine (7348).
Marihuana (7360)...........................  I
Tetrahydrocannabinols (7370)...............  I
Mescaline (7381)...........................  I
3,4,5-Trimethoxyamphetamine (7390).........  I
4-Bromo-2,5-dimethoxyamphetamine (7391)....  I
4-Bromo-2,5-dimethoxyphenethylamine (7392).  I
4-Methyl-2,5-dimethoxyamphetamine (7395)...  I
2,5-Dimethoxyamphetamine (7396)............  I
2,5-Dimethoxy-4-ethylamphetamine (7399)....  I
3,4-Methylenedioxyamphetamine (7400).......  I
5-Methoxy-3,4-methylenedioxyamphetamine      I
 (7401).
N-Hydroxy-3,4-methylenedioxyamphetamine      I
 (7402).
3,4-Methylenedioxy-N-ethylamphetamine        I
 (7404).
3,4-Methylenedioxymethamphetamine (7405)...  I
4-Methoxyamphetamine (7411)................  I
5-Methoxy-N-N-dimethyltryptamine (7431)....  I
Alpha-methyltryptamine (7432)..............  I
Bufotenine (7433)..........................  I
Diethyltryptamine (7434)...................  I
Dimethyltryptamine (7435)..................  I
Psilocybin (7437)..........................  I
Psilocyn (7438)............................  I
5-Methoxy-N-N-diisopropyltryptamine (7439).  I
N-Benzylpiperazine (7493)..................  I
3,4-Methylenedioxypyrovalerone (7535)......  I
3,4-Methylenedioxy-N-methylcathinone (7540)  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Lisdexamfetamine (1205)....................  II
------------------------------------------------------------------------

    The company plans to manufacture small quantities of marihuana 
derivatives for research purposes. In reference to drug code 7360 
(Marihuana), the company plans to bulk manufacture cannabidiol. In 
reference to drug code 7370 (Tetrahydrocannabinols), the company will 
manufacture a synthetic THC. No other activity for this drug code is 
authorized for this registration.
    The company plans to manufacture the remaining listed controlled 
substances to supply these materials to the research and forensics 
community for drug testing and analysis.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Cayman Chemical Company to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Cayman Chemical Company to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed.

    Dated: November 14, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-28500 Filed 11-21-12; 8:45 am]
BILLING CODE 4410-09-P